全球API市场有望在2020年达到1,750亿美元

beiwei5du

GlobalActive Pharmaceutical Ingredient Market Is Expected to Reach $175 Billion by2020; Finds New Report

Market ResearchReports, Inc. has announced the addition of “Active Pharmaceutical IngredientsGlobal Market – Forecast to 2020” research report to their websitehttp://www.MarketResearchReports.com

Lewes, DE -- (ReleaseWire) -- 03/27/2015 -- The global activepharmaceutical ingredient market is expected to reachapproximately $175 billion by 2020, growing at aCAGR of around 6% during forecast period. Active pharmaceuticalingredient is any substance or mixture of substances used in a finishedpharmaceutical product with pharmacological activity used for diagnosis, cure,mitigation, treatment and prevention of diseases. Very less number of finishedpharmaceutical product manufacturers has their own API manufacturing unit andnobody can make all required APIs in-house. It is basically not easy for APImanufacturers in developing countries to ensure a product with quality at areasonable price. API manufacturing involves conversion of raw materials intoAPI and mixing API and excipients for final formulations. These formulations inthe form of tablets, capsules or solutions are packaged and thenmarketed.

Patent expiration of major drugs that increased generic drug sales, governmentinitiatives, increasing aged population and regional penetration, localmanufacturer expansion and high uptake of biologics are some of the factorsthat are driving the market growth. Whereas financial crisis, stringentregulatory policies, less investment in pharmaceutical industry and fragmentedmarket are the factors that are hindering API market growth.

The global API market is segmented based on synthesis, customer base, businesstype and therapeutic applications. Depending on synthesis the market isclassified into synthetic chemical API, biotech API andHPAPI (Highly Potent Active Pharmaceutical Ingredient). Biotech API isfurther segmented into mammalian cell culture, monoclonal antibodies,recombinant proteins, vaccines, insulin analog, growth hormones andinterferons. Mammalian cell culture accounted for thelargest share in 2013, while monoclonal antibody segment is the fastest growingsegment by 2020. Despite low production yields, high manufacturing costand highly unstable cell culturing method mammalian culture is the largest dueto post-translational mechanism present in living cells. Monoclonal antibodiesare growing at a faster pace due to demand for biotech APIs and increasingventure capital investments that drives the market.

By-customer base the API market is segmented intosynthetic chemicals API, biotech API and HPAPI. Synthetic chemical APIis further classified into branded/innovative andgeneric/non-branded API. Branded API accountedfor the largest share whereas, generic is the fastest growing segment. Biotech API is further divided into biologics and biosimilarswhere biologics accounted for the largest share.

Depending on business type the API market is segmentedinto captive and merchant. Captive market accounted for the largest revenue in2013. Based on the therapeutic applications theglobal API market is categorized into eleven crucial application areas such asanti-infectives, oncology, cardiovascular and hematopoietic system, centralnervous system, gastrointestinal disorder, respiratory system, hormonal-relateddisorder, metabolic disorder, genito-urinary disorder, musculo-skeletaldisorder and others. Anti-infectives segmentdominated the application market with a largest in 2013 whereas oncologysegment is the fastest growing segment with a CAGR of approximately 8% by 2020.Patent expiration of major drugs, increased incidence of various cancerdiseases and aged population, high government investments for cancer researchand healthcare awareness are the factors that drives the market whereasstringent regulations, failure of crucial drugs in last stage of clinicaltrial, and economical crisis are the factors that hampers the marketgrowth.

Geographically API market is segmented into NorthAmerica, Asia-Pacific, Europe and Rest of the world regions. NorthAmerica dominated the global API market during the forecast period. AsiaPacific region is the fastest growing with a CAGR of more than 7.5% by 2020 dueto patent expirations of drugs, low operation costs, services of ContractManufacturing Organizations (CMO) and high investments in medical research.Moreover the high cost of skilled labor and energy are the major factors thatforced European market to shift their base to countries such as India andChina.

Major players in the API market include Teva Active Pharmaceutical IndustriesLimited (Israel), Ranbaxy Laboratories (India), Dr. Reddy's Lab (India),Boehringer Ingelheim GmbH (Germany), Lonza group (Switzerland), Lupin (India),Novartis (Switzerland), Aurobindo pharma (India), and Albemarle Corporation(U.S.).

Spanning over 282 pages and 51 Tables "Active Pharmaceutical IngredientsGlobal Market – Forecast to 2020" report covers Executive Summary,Introduction, Market Analysis, Global Api Market Overview, Global Api Market,By Therapeutic Application, Regional Market Analysis, Company Developments,Major Player Profiles. This Report Covered 11 Companies - Teva ActivePharmaceutical Industries Limited (Israel), Ranbaxy Laboratories (India), Dr.Reddy's Lab (India), Boehringer Ingelheim Gmbh (Germany), Lonza Group(Switzerland), Lupin (India), Novartis (Switzerland), Aurobindo Pharma (India),Albemarle Corporation (U.S.), Sun Pharmaceuticals (India), Fresenius Kabi(Germany).

For further information on this report, please visit- http://www.marketresearchreports.com/iq4i/active-pharmaceutical-ingredients-global-market-%E2%80%93-forecast-2020

Find all Pharmaceutical Manufacturing Reports at: http://www.marketresearchreports.com/pharmaceutical-manufacturing

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reportsand market data. We provide you with the latest market research reports onglobal markets, key industries, leading companies, new products and latestindustry analysis & trends.

For regular industry updates subscribe to our newsletter at:http://www.marketresearchreports.com/subscribe-to-newsletter

syhorchid

全球API需求旺盛

wangdaocan

抓住商机啊！